Girling S L, Bell S C, Whitelock R G, Rayward R M, Thomson D G, Carter S C, Vaughan-Thomas A, Innes J F
Small Animal Division, Faculty of Veterinary Science, University of Liverpool, Liverpool L69 0BX, UK.
J Small Anim Pract. 2006 Dec;47(12):708-14. doi: 10.1111/j.1748-5827.2006.00150.x.
To evaluate the hypothesis that the concentration of the 1/20/5D4 epitope of keratan sulphate, cartilage oligomeric matrix protein and total sulphated glycosaminoglycans in synovial fluids from dogs with cranial cruciate ligament disease would be affected by tibial plateau levelling osteotomy. In addition, to evaluate the hypothesis that medial meniscal release or meniscal injury would alter the expression of these candidate biomarkers.
Forty-one dogs with naturally occurring cranial cruciate ligament disease were recruited prospectively. Synovial fluids were collected from the index joint before surgery and six weeks and six months postsurgery. Following tibial plateau levelling osteotomy, synovial fluids were assayed for 1/20/5D4 epitope of keratan sulphate and cartilage oligomeric matrix protein concentration using an inhibition ELISA and for sulphated glycosaminoglycans using a direct dye-binding assay.
The sulphated glycosaminoglycans ratio did not change significantly during the study. Medial meniscal injury at entry was associated with lower concentrations of synovial fluid cartilage oligomeric matrix protein (P<0.05, unpaired t test). There was no association between medial meniscal release and the changes in marker concentrations, either from 0 to six weeks or 0 to six months.
Tibial plateau levelling osteotomy did not significantly alter the expression of the named candidate biomarkers. These findings reflect the limited nature of the arthrotomy or indicate that tibial plateau levelling osteotomy does not influence the progression of osteoarthritis (OA). From these studies, there is no evidence that tibial plateau levelling osteotomy affects cartilage metabolism.
评估以下假说,即患有前交叉韧带疾病的犬类滑液中硫酸角质素的1/20/5D4表位、软骨寡聚基质蛋白和总硫酸化糖胺聚糖的浓度会受到胫骨平台水平截骨术的影响。此外,评估内侧半月板松解或半月板损伤会改变这些候选生物标志物表达的假说。
前瞻性招募41只患有自然发生的前交叉韧带疾病的犬。在手术前、术后六周和六个月从患侧关节收集滑液。在胫骨平台水平截骨术后,使用抑制酶联免疫吸附测定法检测滑液中硫酸角质素的1/20/5D4表位和软骨寡聚基质蛋白浓度,使用直接染料结合测定法检测硫酸化糖胺聚糖。
在研究期间,硫酸化糖胺聚糖比率没有显著变化。入组时内侧半月板损伤与滑液软骨寡聚基质蛋白浓度较低相关(P<0.05,非配对t检验)。内侧半月板松解与标记物浓度从0至六周或0至六个月的变化之间没有关联。
胫骨平台水平截骨术并未显著改变所命名的候选生物标志物的表达。这些发现反映了关节切开术的局限性,或表明胫骨平台水平截骨术不影响骨关节炎(OA)的进展。从这些研究中,没有证据表明胫骨平台水平截骨术会影响软骨代谢。